Literature DB >> 26429662

Vitamin A exerts its antiinflammatory activities in colitis through preservation of mitochondrial activity.

Ram Reifen1, Eran Levy2, Zippi Berkovich2, Oren Tirosh2.   

Abstract

OBJECTIVES: The aim of this study was to assess the protective effects of vitamin A in a rat model of colitis to elucidate a possible mechanism of action.
METHODS: Male rats were fed for 21 d with either a normal diet or high vitamin A diet (5000 IU/d). On day 22, colitis was induced with 2,4,6-trinitrobenzenesulfonic acid (TNBS). Rats were sacrificed after 24 h and colonic tissue was removed for evaluation.
RESULTS: Morphologically, in the supplemented group preservation of tissue architecture, no vasculitis or necroses were detected. Biochemically, decreased myeloperoxidase activity and protection of the mitochondria as evaluated by preserving tissue oxygen consumption, mitochondrial DNA, and expression of cytochrome c, was observed. Vitamin A supplementation also increased the levels of nuclear respiratory factor (NFR)-1 and mitochondrial transcription factor-A (TFAM) in normal colon tissue and in colon tissue under inflammatory conditions.
CONCLUSION: The results indicate that tissue damage in colitis is accompanied by the arrest of mitochondrial respiration, loss of mitochondrial DNA, and the expression of mitochondrial proteins. Vitamin A effectively protects colon mitochondria by upregulation of mitochondrial transcription factors, NFR-1 and TFAM, and prevents inflammatory and necrotic changes in colitis. Vitamin A is therefore a potential therapeutic agent in inflammatory bowel disease.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Colitis; Inflammatory bowel disease; Mitochondria; Vitamin A; Vitamin A supplementation

Mesh:

Substances:

Year:  2015        PMID: 26429662     DOI: 10.1016/j.nut.2015.05.011

Source DB:  PubMed          Journal:  Nutrition        ISSN: 0899-9007            Impact factor:   4.008


  7 in total

Review 1.  Altered nutrient status reprograms host inflammation and metabolic health via gut microbiota.

Authors:  Rachel M Golonka; Xia Xiao; Ahmed A Abokor; Bina Joe; Matam Vijay-Kumar
Journal:  J Nutr Biochem       Date:  2020-02-22       Impact factor: 6.048

2.  Therapeutic effects of sulforaphane in ulcerative colitis: effect on antioxidant activity, mitochondrial biogenesis and DNA polymerization.

Authors:  Abdullah Alattar; Reem Alshaman; Mohammed M H Al-Gayyar
Journal:  Redox Rep       Date:  2022-12       Impact factor: 5.696

3.  Quantitative analysis of mucosal oxygenation using ex vivo imaging of healthy and inflamed mammalian colon tissue.

Authors:  Alexander V Zhdanov; Irina A Okkelman; Anna V Golubeva; Barbara Doerr; Niall P Hyland; Silvia Melgar; Fergus Shanahan; John F Cryan; Dmitri B Papkovsky
Journal:  Cell Mol Life Sci       Date:  2016-08-10       Impact factor: 9.261

4.  Anti-Inflammatory Properties of the Enaminone E121 in the Dextran Sulfate Sodium (DSS) Colitis Model.

Authors:  Maitham A Khajah; Kethireddy V Ananthalakshmi; Ivan Edafiogho
Journal:  PLoS One       Date:  2016-12-20       Impact factor: 3.240

Review 5.  Modulation of Intestinal Immune and Barrier Functions by Vitamin A: Implications for Current Understanding of Malnutrition and Enteric Infections in Children.

Authors:  Pedro Henrique Q S de Medeiros; Daniel V Pinto; Juliana Zani de Almeida; Juliana M C Rêgo; Francisco A P Rodrigues; Aldo Ângelo M Lima; David T Bolick; Richard L Guerrant; Reinaldo B Oriá
Journal:  Nutrients       Date:  2018-08-21       Impact factor: 5.717

Review 6.  Diets, functional foods, and nutraceuticals as alternative therapies for inflammatory bowel disease: Present status and future trends.

Authors:  Mohammad Al Mijan; Beong Ou Lim
Journal:  World J Gastroenterol       Date:  2018-07-07       Impact factor: 5.742

7.  Mitochondrial transcription factor A plays opposite roles in the initiation and progression of colitis-associated cancer.

Authors:  Shirong Yang; Xianli He; Jing Zhao; Dalin Wang; Shanshan Guo; Tian Gao; Gang Wang; Chao Jin; Zeyu Yan; Nan Wang; Yongxing Wang; Yilin Zhao; Jinliang Xing; Qichao Huang
Journal:  Cancer Commun (Lond)       Date:  2021-06-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.